Cancer Biopsy market report provides a comprehensive analysis ... circulating tumor cells (CTCs), and exosomes from blood samples. This approach supports early diagnosis, treatment monitoring ...

The global Breast Biopsy Devices Market, valued at US$2,255.0 million in 2024, is forecasted to grow at a robust CAGR of 6.5%, reaching US$2,384.1 million in 2025 and an impressive US$3,261.7 million ...

Inc. reaches a milestone in prostate cancer diagnostics with its clinically validated SUREcore® biopsy needle and coreCARE® ...

Guardant Health, Inc. (NASDAQ:GH) has introduced major upgrades to its Guardant360 Liquid biopsy test, significantly ...

The lung cancer diagnostics market encompasses tools, techniques, and services for detecting lung cancer, including imaging, ...

“Usually, women are unaware that they have fibroids in the uterus, only finding out during an ultrasound scan. If left untreated, these growths can disrupt daily life, especially if symptomatic, such ...

Guardant Health, Inc. , a leading precision oncology company, today announced major new features for the Guardant 360® Liquid test that greatly expand its biomarker identification and cancer subtyping ...

The liposarcoma pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage liposarcoma drugs, inactive and dormant assets, a comprehensive ...

At least twice as many patients on the approved spesolimab dose maintain improvement in skin symptoms and quality of life ...

Pittsburgh OB-GYNs and researchers said new guidelines that urge physicians to take seriously the pain associated with ...

Discover the signs that indicate health issues when your cat vomits. Get insights on 'cat vomit when to worry' and take ...